Angel Invest Boston

Angel-scale biotech is hot! Learn More Psychiatrist and founder Jacqueline Olds on her startup and her mission to fight loneliness in America. Words of wisdom and lots of laughs in this interview that could actually make your life better. Brought to you by: Purdue University entrpreneurship, and Peter Fasse, patent attorney at Fish & Richardson   Highlights:   Sal Daher Introduces, Jacqueline Olds...

The Promise of Angel-Scale Biotech: Learn More The miracle-working CEO of portfolio company Finetune Learning is back to tell us about the latest developments in applying artificial intelligence in educational assessments. We also got into remote work and explored how to support younger workers in creating professional networks while working remotely. Sponsored by: Purdue University entrepreneursh...

The Promise of Angel-Scale Biotech: Learn More SPVs (Special Purpose Vehicles) are democratizing startup investing. In this interview with Jeremy Neilson, founder of Assure.co, we discussed how founders and angels can benefit from these increasingly economical platforms and what they mean for the future. Highlights: Sal Daher Introduces Jeremy Neilson Co-Founder of Assure.co Sal and Jeremy Met at...

The Opportunitites in Angel-Scale Biotech: https://syndicate.angelinvestboston.com/en-us/the-surge-of-opportunities-in-angel-scale-biotech The dynamic duo of founder Adam Martel and super angel Christopher Mirabile are back on the podcast to report on the sale of Gravyty and to discuss Adam's new startup, Givzey. Highlights: Gravyty Created a New Category How COVID Affected Gravyty Merging Gravyty...

Why Sal Is Bullish on Biotech: Click Here Adam de Sola Pool, a highly successful pioneer in green tech investing in the 1990s, now sees huge opportunities in blue tech.  Don't miss this fascinating tour of ocean technologies conducted by an engaging investor/guide. Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish & Richardson Highlights: Sal Daher Welcomes B...

Why Sal Is Bullish on Biotech VeraMorph has a new way to deliver insoluble drugs by mouth. Founder Doug Godfrin, PhD elucidates the promise of accessing the 85% of drugs that are not soluble. Does VeraMorph pass Sal Daher's screen for angel-scale biotech? Listen and find out. Sponsors: Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson Highlights: Sal Daher,...

Click to Learn About Opportunities in Angel-Scale Biotech Diane Stokes, founder and angel investor, is back to update us on her startups. This inspiring triathlete has great ideas for startups who want to scale. Highlights: Sal Daher Welcomes Back Iron Woman Diane Stokes, Founder & Angel This Interview Picks Up Where the Prior Interview Left Off – Back to Wyebot How Wyebot Weathered COVID Diane St...

Join Sal's Syndicate: https://syndicate.angelinvestboston.com/en-us/the-surge-of-opportunities-in-angel-scale-biotech Artificial intelligence guru Gil Syswerda is back to talk about angel investing and to give practical advice to founders. We closed with entertaining stories from Gil's career. Highlights: AI Guru Gil Syswerda Is Back to with Tips for Angels & Founders Why Founders Should Value The...

Why Sal's Bullish on Angel-Scale Biotech: Learn More Sponsored by Purdue University entrepreneurship and peter Fasse, patent attorney at Fish & Richardson Founder Matt Breen of Rahoo Baby is back to update us on the progress of the company and on their new product, Walk Block. This startup is building a brand around helping parents support the cognitive development of their babies. Highlights: Sal...

When Semyon Dukach's family came to America as refugees from the Soviet Union, they had a hundred dollars to their name. Semyon is now one of Boston's most consequential VCs. Along the way he founded a couple of startups himself and made some remarkable angel investments that put him in a position to be helping founders with money and time. He has a knack for encouraging founders during the tough...

Join Sal's Investment Syndicate: Click to Join Listener Robert Nagle is a mathy software guy and an angel investor. We had a great chat which included his perceptions of the risks in biotech investing and also discussed some of the companies in his portfolio. This is an instructive conversation with a thoughtful angel investor. Sponsored by: Purdue University entrepreneurship Peter Fasse, patent a...

When Sid Satish saw his first surgery he was struck by the contrast between the advanced technologies in use side by side with ancient practices such as the negotiation over how much patient blood has been lost. He saw an opportunity to apply technology to create an informed calculation of blood loss. This was in 2011, now this technology runs on iPad Pros and is in use at 30 hospitals. In the fal...

Join Sal's Investment Syndicate: Click to Join Salvatore Viscomi, MD founded his own startup and is now with GoodCell which isolates and stores cells of healthy patients who may need them for future cell therapies. The startup is founded by David Scadden, MD of the Harvard Stem Cell Institute. A truly informative interview. Sponsored by Purdue University entrepreneurship and Peter Fasse, patent at...

Sal's Syndicate: Click to Join Virtual visits & robotics to improve greatly the recovery of stroke patients. Chrissy Glover & her startup, Imago Rehab, are taking to market technology from Harvard's Biodesign Lab informed by deep experience in how stroke rehabilitation is done now. Highlights: Sal Daher Introduces Chrissy Glover, Co-Founder of Imago Rehab "...they've had a stroke maybe a year ago,...

Sal's Investment Syndicate: Click to Join Harvard's Tom Eisenmann is the author of Why Startups Fail: A New Roadmap for Entrepreneurial Success . We discussed valuable lessons from the book and how they might apply to biotech startups. Highlights: Sal Daher Introduces Prof. Tom Eisenmann of the Harvard Business School, Author of Why Startups Fail Howard Stevenson's 400X Return Contrasting Brad Fel...

Join Sal's Syndicate: Click to Join Genius founder Sam Bogoch of Axle.ai returns to the podcast to tells us the secrets of equity crowdfunding. Axle.ai helps enterprises with massive video files make them usable. The startup has found great success on Republic and Sam has wisdom to share. Highlights: Sal Daher Introduces Sam Bogoch Founder of Axle.ai Who Is a Returning Guest Sam Bogoch's Back Stor...

Join Sal's Syndicate: https://www.angelinvestboston.com/our-syndicates Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish & Richardson Hesitant about investing in biotech startups? Founder Çağrı Savran and I discuss the unique opportunities and requirements of angel-scale life science startups. This is the first in a series of biotech angel bootcamps. Highligh...

Sal' Syndicate: Click to Join Artificial General Intelligence (AGI) is the whole ball game. Whoever gets it first will rule. Who's ahead and how to bet on them; this is only part of the excellent second chat with AI wiz Gil Syswerda. Highlights: Sal Daher Introduces Second Installment of Interview – AI and the Future Sponsors: Purdue University entrepreneurship, and Peter Fasse, patent attorney at...

Sponsors: Purdue University entrepreneurship Peter Fasse, patent attorney at Fish & Richardson Mostly diagnosed in late stages, ovarian cancer is a silent killer of women. Oriana Papin-Zoghbi of AOA Dx aims to defeat this threat. Fresh out of Y Combinator, the team is making impressive headway in commercializing a promising technology from McGill University. Highlights: Sal Introduces Sponsors, Pu...

Sal's Syndicate: https://www.angelinvestboston.com/our-syndicates Sponsored by: Purdue University Entrepreneurship Peter Fasse, patent attorney at Fish & Richardson The best measure of a founder is how much she can get done with limited resources. By this metric, Bryanne Leeming is an outstanding founder. Two years before she had a paper prototype and vague hopes for a Kickstarter program. At the...

Sal's Investment Syndicate: Click to Join Sponsored by: Purdue University entrepreneurship Peter Fasse, patent attorney at Fish & Richardson I invested in Savran Tech back in 2017 around the time of the first part of this interview. Recently I sat down with Cagri Savran to review the progress of his remarkable biotech startup in the last four years. Listen to the original interview followed by a r...

Sponsored by: Purdue University entrepreneurship Peter Fasse, patent attorney at Fish & Richardson In December of 2017 I interviewed Çağrı Savran, Ph. D. about plans for his startup in which I had just invested. Almost four years later I interviewed him again to review the progress of the company which is changing the way breast cancer is followed up after treatment. Highlights: Update on the Orig...

Sponsored by: Purdue University Entrepreneurship Peter Fasse, Patent Attorney at Fish & Richardson AI wiz, founder and angel investor Gil Syswerda on building algorithms and companies. This episode focuses on Gil's biography and his startups. It's the first in-studio interview since spring 2020. We had a blast! Highlights: Sal Daher Introduces Gil Syswerda, Founder and Super Angel Gil Syswerda Luc...

Sponsored by: Purdue University Entrepreneurship Peter Fasse, Patent Attorney at Fish & Richardson Medical records are way less informative to doctors than patients imagine. Electronic health records (EHRs) have failed to deliver on their promise to improve health care for forty years. Ryan Hess, founder of Connective Health, means to change that. I invited digital health founder Martín Aboitiz to...

A curious but orderly mind prepared to take advantage of serendipity has taken Adam de Sola Pool on a remarkable journey during his career. His father, Ithiel de Sola Pool, the brilliant political scientist (look up Six Degrees of Separation or Convergence) took young Adam to many different countries. These travels sparked in Adam an interest in geography which led to a job on Wall Street. From Sa...